Market Cap 46.46M
Revenue (ttm) 138.10M
Net Income (ttm) 31.87M
EPS (ttm) N/A
PE Ratio 1.67
Forward PE 2.57
Profit Margin 23.08%
Debt to Equity Ratio 0.00
Volume 907,800
Avg Vol 1,941,536
Day's Range N/A - N/A
Shares Out 80.10M
Stochastic %K 40%
Beta 1.33
Analysts Strong Sell
Price Target $4.69

Latest News on CTMX

CytomX Therapeutics Announces New Employment Inducement Grants

May 16, 2024, 4:15 PM EDT - 11 months ago

CytomX Therapeutics Announces New Employment Inducement Grants


CytomX stock down 30% despite encouraging cancer study results

May 9, 2024, 9:10 AM EDT - 11 months ago

CytomX stock down 30% despite encouraging cancer study results